Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PerkinElmer, Inc.

https://www.perkinelmer.com/

Latest From PerkinElmer, Inc.

Agios Anticipates PK Deficiency Diagnosis Ramp-Up After Pyrukynd Approval

The company hopes to grow the current diagnostic rate from 30% to 70% over two to five years. “Optimal reimbursement” for mitapivat will likely take a year, with Medicare/Medicaid lagging.

Approvals Blood & Coagulation Disorders

PerkinElmer To Buy UK-Based Immunodiagnostics For $155M

PerkinElmer will add chemiluminescence products in endocrinology, autoimmunity and diagnostics to its portfolio with the planned buyout of Immunodiagnostics.

M & A Deals
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Services
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
  • Other Names / Subsidiaries
    • Bioo Scientific Corporation
UsernamePublicRestriction

Register